Syschem (India) Ltd.
Snapshot View

9.55 -0.36 ▼-3.6%

03 August 2021, 04:00:00 P.M.
Volume: 56,159

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syschem.in
Financial Indicators
Market Cap 21.35 Cr.
Earnings per share (EPS) -3.10 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-06
Industry PE 32.66 Trailing Twelve Months Ending 2021-06
Book Value / Share 2.56 Trailing Twelve Months Ending 2021-06
Price to Book Value 3.87 Calculated using Price: 9.91
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 2.15 Cr. 21,540,400 Shares
FaceValue 10
Company Profile

Syschem India was incorporated on December 31, 1993 as Anil Pesticides and obtained certificate of commencement of business on February 1, 1994. The company is promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla.

Anil Pesticides has taken effective steps for putting up a project for manufacturing pesticides' namely Monocrotophos (MCP) and Dichlorvos (DDVP). The project is being put up with equity participation of Haryana State Industrial Development Corporation, an undertaking of the Government of Haryana.

The registered office of the company is located at Tehsil Kalka, District Panchkula, Punchkula, Haryana 134109.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-3.63%
1 Week
-16.52%
1 Month
+15.20%
3 Month
+40.44%
6 Month
+30.29%
1 Year
+52.56%
2 Year
+52.56%
5 Year
+36.82%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 3.33 7.66 4.37 -32.44 -25.21 -19.78 4.43 7.67 -17.24
Return on Capital Employed (%) 4.58 7.76 7.88 -10.60 -8.30 -6.68 2.68 5.51 -8.22
Return on Assets (%) 1.48 2.50 1.16 -7.41 -4.69 -3.41 0.69 1.30 -3.06

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 13 14 15 11 9 7 9 12 10
Non Curr. Liab. 13 22 22 20 19 13 12 11 12
Curr. Liab. 5 11 17 19 18 22 34 37 39
Minority Int.
Equity & Liab. 31 48 55 50 45 42 56 61 61
Non Curr. Assets 24 36 37 35 33 31 30 28 30
Curr. Assets 7 12 17 15 13 11 26 32 31
Misc. Exp. not W/O
Total Assets 31 48 55 50 45 42 56 61 61

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 11 16 18 11 4 13 67 93 77
Other Income 0 0 1 0 0 0 0
Total Income 11 16 20 11 4 13 67 93 77
Total Expenditure -9 -12 -14 -14 -5 -13 -63 -90 -77
PBIDT 2 4 5 -3 -1 0 3 4 0
Interest 0 -1 -3 -1 0 0 0 0 0
Depreciation -1 -1 -2 -2 -2 -2 -2 -2 -2
Taxation 0 0 0 1 1 1 0 -1 0
Exceptional Items 0
PAT 0 1 1 -4 -2 -1 0 1 -2

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 4 4 1 0 6 0 -2 3
Cash Fr. Inv. -14 -13 -3 0 0 0 0 2 -4
Cash Fr. Finan. 15 10 -1 -2 -1 -7 0 0 0
Net Change 0 1 0 -1 0 0 0 0 0
Cash & Cash Eqvt 0 1 1 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 23.59 23.80 13.16 10.50 10.54 9.54 9.54 9.54 9.54
Public 76.41 76.20 86.84 89.49 89.46 90.46 90.46 90.46 90.46
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 45.11 44.71 16.18 20.28 20.20 19.47 19.47 19.47 19.47

Announcements View Details

Tue, 03 Aug 2021
Reg. 34 (1) Annual Report
Pursuant to Regulation 34 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached herewith Annual Report of the Company for the Financial Year 2020-21.

This is for your information and Record please
Tue, 03 Aug 2021
Notice Of Annual General Metting 2021
Dear Sir

Pursuant to Regulation 34 of the SEBI (Listing Obligation and Disclosure requirements)Regulations 2015 please find attached herewith Revised Annual Report of the Company for the financial Year 2020-21.
Tue, 03 Aug 2021
Reg. 34 (1) Annual Report
Dear Sir
Pursuant to Regulation 34 of the SEBI (Listing Obligation and Disclosure requirements) Regulations 2015 please find attached herewith Revised Annual Report of the Company for the financial Year 2020-21.
This is for your information and record please.

Technical Scans View Details

Mon, 02 Aug 2021
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
S Close Below Last Week Low

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 185,816.50 794.85 +2.6%
Divi's Laboratories Ltd. 130,822.92 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. 78,219.21 4,721.20 +0.4%
Cipla Ltd. 74,356.30 927.25 +0.6%
Cadila Healthcare Ltd. 60,574.85 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. 58,218.41 4,076.05 +0.7%
Piramal Enterprises Ltd. 56,317.82 2,507.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 30.95 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2021-03 65.93 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.02 4,721.20 +0.4%
Cipla Ltd. Consolidated 2021-03 30.92 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.39 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 387.19 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 42.27 2,507.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.88 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2021-03 14.08 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.37 4,721.20 +0.4%
Cipla Ltd. Consolidated 2021-03 4.06 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.66 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.67 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1.65 2,507.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 0.18 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,507.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 10.09 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,507.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 12.53 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,507.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,507.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,507.65 +0.7%